Φορτώνει......
Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches
Precision oncology is now the evidence-based standard of care for the management of many advanced non-small cell lung cancers (NSCLCs). Expert consensus has defined minimum requirements for routine testing and identification of epidermal growth factor (EGFR) mutations (15% of tumors harbor EGFR exon...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Respir Dis |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933559/ https://ncbi.nlm.nih.gov/pubmed/26620497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465815617871 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|